Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation
- 27 October 2003
- journal article
- immunobiology
- Published by Wolters Kluwer Health in Transplantation
- Vol. 76 (8) , 1214-1220
- https://doi.org/10.1097/01.tp.0000088672.48259.f1
Abstract
Background. Recent studies have shown the possible role of growth factors and the involvement of macrophages as a source of them in the pathogenesis of bronchiolitis obliterans (BO) after lung transplantation. Objective. The authors intended to determine whether depletion of recipient macrophages by gadolinium chloride (GdCl3) resulted in decreased obliterative airway disease (OAD) in a rat model of heterotopic tracheal transplantation. Methods. A tracheal segment of donor rats (Brown Norway) was transplanted into a subcutaneous pouch of fully major histocompatibility complex-incompatible recipient rats (Lewis). Recipients were injected intravenously with 80 mg/kg of GdCl3·6H2O or saline on days 0, 7, and 14 posttransplant. Allografts were harvested on days 7, 14, 17, and 21 and the degree of OAD resulting from fibroproliferative tissue was pathologically scored on a scale of 0 to 4. A portion of allografts was submitted to reverse-transcriptase polymerase chain reaction analysis to examine mRNA expression for platelet-derived growth factor (PDGF), basic fibroblast growth factor, and transforming growth factor-β1. Results. Immunohistochemical studies confirmed reduction in the number of ED2+ macrophages in tracheal allografts by GdCl3 injection. GdCl3 treatment significantly decreased OAD of allografts, with the histologic score of 1.4±0.3 in the treated animals compared with 3.0±0.5 in the controls (mean±SE, P =0.02) at day 21 posttransplant, and this was accompanied by decreased PDGF-A and PDGF-B gene expression in the GdCl3 group at day 17 posttransplant. Conclusions. Macrophage reduction by GdCl3 resulted in significantly decreased OAD development and reduced PDGF mRNA expression in allografts. This suggests a potential effectiveness of therapies targeting recipient macrophages in preventing BO after lung transplantation.Keywords
This publication has 16 references indexed in Scilit:
- The Registry Of The International Society For Heart And Lung Transplantation: Nineteenth Official Report—2002The Journal of Heart and Lung Transplantation, 2002
- LYMPHOCYTIC AIRWAY INFILTRATION AS A PRECURSOR TO FIBROUS OBLITERATION IN A RAT MODEL OF BRONCHIOLITIS OBLITERANS1,2Transplantation, 1997
- GADOLINIUM CHLORIDE-INDUCED MACROPHAGE BLOCKADE PREVENTS REJECTION OF HUMAN INSULINOMA CELL XENOGRAFT IN RATS1Transplantation, 1997
- Lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1997
- Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group.American Journal of Respiratory and Critical Care Medicine, 1996
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1995
- PATHOGENESIS OF OBLITERATIVE BRONCHIOLITISTransplantation, 1995
- Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1992
- Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulationJournal of Leukocyte Biology, 1992
- Lung Immunogenicity, Rejection, and Obliterative BronchiolitisChest, 1987